<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ngai D</submitter><funding>American Heart Association</funding><funding>NCRR NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | National Institutes of Health</funding><pagination>2206-2219</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10782856</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(12)</volume><pubmed_abstract>The clearance of apoptotic cells by macrophages (efferocytosis) prevents necrosis and inflammation and activates pro-resolving pathways, including continual efferocytosis. A key resolution process in vivo is efferocytosis-induced macrophage proliferation (EIMP), in which apoptotic cell-derived nucleotides trigger Myc-mediated proliferation of pro-resolving macrophages. Here we show that EIMP requires a second input that is integrated with cellular metabolism, notably efferocytosis-induced lactate production. Lactate signalling via GPR132 promotes Myc protein stabilization and subsequent macrophage proliferation. This mechanism is validated in vivo using a mouse model of dexamethasone-induced thymocyte apoptosis, which elevates apoptotic cell burden and requires efferocytosis to prevent inflammation and necrosis. Thus, EIMP, a key process in tissue resolution, requires inputs from two independent processes: a signalling pathway induced by apoptotic cell-derived nucleotides and a cellular metabolism pathway involving lactate production. These findings illustrate how seemingly distinct pathways in efferocytosing macrophages are integrated to carry out a key process in tissue resolution.</pubmed_abstract><journal>Nature metabolism</journal><pubmed_title>Efferocytosis-induced lactate enables the proliferation of pro-resolving macrophages to mediate tissue repair.</pubmed_title><pmcid>PMC10782856</pmcid><funding_grant_id>S10 OD020056</funding_grant_id><funding_grant_id>S10 RR027050</funding_grant_id><funding_grant_id>R35-HL145228</funding_grant_id><funding_grant_id>P01 HL087123</funding_grant_id><funding_grant_id>900337</funding_grant_id><funding_grant_id>R35 HL145228</funding_grant_id><funding_grant_id>P30 CA013696</funding_grant_id><pubmed_authors>Schilperoort M</pubmed_authors><pubmed_authors>Tabas I</pubmed_authors><pubmed_authors>Ngai D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efferocytosis-induced lactate enables the proliferation of pro-resolving macrophages to mediate tissue repair.</name><description>The clearance of apoptotic cells by macrophages (efferocytosis) prevents necrosis and inflammation and activates pro-resolving pathways, including continual efferocytosis. A key resolution process in vivo is efferocytosis-induced macrophage proliferation (EIMP), in which apoptotic cell-derived nucleotides trigger Myc-mediated proliferation of pro-resolving macrophages. Here we show that EIMP requires a second input that is integrated with cellular metabolism, notably efferocytosis-induced lactate production. Lactate signalling via GPR132 promotes Myc protein stabilization and subsequent macrophage proliferation. This mechanism is validated in vivo using a mouse model of dexamethasone-induced thymocyte apoptosis, which elevates apoptotic cell burden and requires efferocytosis to prevent inflammation and necrosis. Thus, EIMP, a key process in tissue resolution, requires inputs from two independent processes: a signalling pathway induced by apoptotic cell-derived nucleotides and a cellular metabolism pathway involving lactate production. These findings illustrate how seemingly distinct pathways in efferocytosing macrophages are integrated to carry out a key process in tissue resolution.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Dec</publication><modification>2025-04-04T01:17:59.256Z</modification><creation>2025-04-04T01:17:59.256Z</creation></dates><accession>S-EPMC10782856</accession><cross_references><pubmed>38012414</pubmed><doi>10.1038/s42255-023-00921-9</doi></cross_references></HashMap>